Sony’s plans to wind down disc production for its game consoles have met with fury (and memes) across the board. But this decision was driven by many of the same factors squeezing IT generally: ...

Hopes that anti-tau drugs could join those targeting amyloid as treatments for Alzheimer's disease have been dented by the failure of a phase 2b trial of Johnson & Johnson's posdinemab. The AuTonomy ...

Rust enters the top 10 for the first time, Python keeps the lead, C moves back above C++, and SQL edges out R in July’s rankings update. Rust has entered the TIOBE Index top 10 for the first time in ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...